Fsd Pharma (TSE:HUGE) has released an update.
FSD Pharma Inc. has been notified by Nasdaq of non-compliance with its minimum bid price rule but remains listed as it seeks to remedy the issue within a 180-day grace period ending on October 2, 2024. The company is considering options to meet the minimum bid requirement and maintains listings on the Canadian Securities Exchange and the Frankfurt Stock Exchange, with business operations continuing unaffected.
For further insights into TSE:HUGE stock, check out TipRanks’ Stock Analysis page.
